Evidence on the safety of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension shows the potential for serious but well-recognised complications. In relation to efficacy: ...

BARCELONA, Spain—New guidelines for the diagnosis and treatment of pulmonary hypertension (PH), released at the recent European Society of Cardiology (ESC) Congress 2022, include a new hemodynamic ...

Please provide your email address to receive an email when new articles are posted on . There is generally high awareness surrounding the 2022 guidelines for pulmonary hypertension, although some gaps ...

Panelists discuss how pulmonary arterial hypertension diagnosis requires comprehensive evaluation including right heart catheterization to confirm hemodynamic criteria, with normal mean PA pressure ...

Group 1 pulmonary hypertension (or pulmonary arterial hypertension) is a rare, highly complex, and progressive disorder that is incurable and ultimately can lead to premature death. PAH causes ...

Earlier detection of pulmonary hypertension in the community and expedited referral of high-risk or complex patients are recommended in the European Society of Cardiology (ESC) and European ...

Prof Jay Suntharalingam and Dr Gerry Coghlan join the Clinical Excellence in Respiratory Care speakers to discuss pulmonary ...

New European Society of Cardiology (ESC)/European Respiratory Society (ERS) guidelines for diagnosis and treatment of pulmonary hypertension have lowered the cutoff for defining pulmonary hypertension ...

Pulmonary arterial hypertension is characterized by pulmonary vascular remodeling, cellular proliferation, and poor long-term outcomes. Dysfunctional bone morphogenetic protein pathway signaling is ...

There is the potential for serious complications with balloon pulmonary angioplasty, but it works well enough for use in the NHS for patients with chronic thromboembolic pulmonary hypertension in whom ...